Maraviroc: a new CCR5 antagonist (Q37557671)

21 August 2017

1 reference

title

Maraviroc: a new CCR5 antagonist (English)

1 reference

21 August 2017

0 references

Shilpa Sayana

1 reference

21 August 2017

Homayoon Khanlou

series ordinal

1 reference

21 August 2017

publication date

1 February 2009

1 reference

Expert Review of Anti-infective Therapy

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

9-19

1 reference

Co-receptor antagonists as HIV-1 entry inhibitors.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Biology of CCR5 and its role in HIV infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Chemokine antagonists as therapeutics: focus on HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

CCR5 inhibitors: promising yet challenging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

21 January 2018

HIV entry inhibitors.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.9

21 January 2018

Identifiers

DOI

10.1586/14787210.7.1.9

1 reference

21 August 2017

1 reference